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A B S T R A C T   
Increased systemic inflammation has been identified in presence of oral disease, specifically endodontic disease. 
It is important to investigate whether treatment of the oral disease ameliorates systemic inflammation. 
Furthermore, there is no information about the extent to which different microorganisms may trigger inflam-
matory response. 
Objectives: Primarily (i) to compare the plasma concentrations of inflammatory mediators of apical periodontitis 
(AP) subjects to controls, (ii) to evaluate whether elimination of the endodontic infection reduces systemic 
inflammation (iii) to investigate the microbiome of root canal infections. Secondarily i) to correlate the in-
flammatory mediator data with the microbiome data to investigate whether the type of infection influences the 
type and severity of the inflammatory condition ii) to examine patterns in the inflammatory mediator data before 
and after tooth extraction in order to establish a biomarker signature of AP/oral disease. 
This is a multi-centre prospective case-control intervention study. The cohort will consist of 30 healthy human 
volunteers with one or two teeth with a root-tip inflammation and 30 matched healthy controls. Peripheral blood 
will be drawn at 6 time points, 3 before and 3 after the extraction of the tooth with apical periodontitis. The teeth 
will be pulverized, DNA extraction and sequencing will be performed. 
This study aims to compare the concentration of inflammatory blood plasma proteins in between AP-subjects and 
controls at different time points before and after the tooth extraction in a systematic and complete way. Addi-
tionally the composition of the root canal microbiome in association with the inflammatory response of the host 
will be assessed.   
1. Introduction 
Inflammatory mediators (IMs) can be found in healthy as well as in 
diseased individuals and is part of the complex biological response of 
body tissues to harmful stimuli. When looking at reference blood values 
of healthy, disease-free, individuals it has become clear that even in 
disease-free humans in peripheral blood, soluble mediators of inflam-
mation can be detected [1]. These inflammatory mediators (IMs) are 
cytokines, chemokines, acute-phase proteins, soluble adhesion proteins 
etc. and they are present as a result of homeostasis. Homeostasis is a 
property of a system in which variables are regulated such that internal 
conditions remain stable and relatively constant even when in the 
presence of harmful stimuli. As stated, these ‘healthy’ IMs are the same 
that can be found in disease and it is when the load of these regulated 
variables becomes sufficiently great, that the system fails to balance 
leading to pathophysiology [2–4] In general, the concentration of IMs 
are lower in health than in disease. This continuous presence of IMs in an 
apparently healthy individual is also called systemic inflammation or 
low-grade inflammation. Knowing that disease increases low-grade 
inflammation, gives us a tool to measure the impact of disease, 
including oral disease, on systemic health. 
Amongst the most common oral diseases is, apical periodontitis (AP) 
an infection of the root canal system resulting from ingress of micro- 
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organisms from the oral cavity [5]. When the integrity of the surface 
layers of a tooth crown is lost due to dental caries or trauma, oral 
micro-organisms gain access to the dental pulp. If the microbial load 
exceeds the ability of the dental pulp to repair, the dental pulp becomes 
necrotic and the empty root-canal system becomes populated with 
micro-organisms. At the root-tip the, now heavy, bacterial load of the 
root-canal system comes in contact with the periodontal ligament. Mi-
crobial products and micro-organisms drive inflammatory changes in 
this structure leading to recruitment of inflammatory cells and bone 
resorption which is characteristic of AP [5,6]. 
A connection between chronic oral infections and the development 
of adverse systemic health conditions has been historically established 
[7]). Emerging evidence supports this with new studies proving links 
between oral bacteria and diseases such as Alzheimer’s disease [8]), 
cardiovascular disease [9] and metabolic syndrome [10]. In the field of 
endodontics, more specifically, connections between existing illness and 
apical periodontitis have been made [11,12]. The burden of apical 
periodontitis on healthy individuals has been also examined. According 
to a systematic review and meta-analysis we conducted recently, sys-
temically healthy individuals with apical periodontitis presented higher 
C reactive protein (CRP) values than healthy individuals without AP 
[13]. These values are related to an increased risk of cardiovascular 
events [14]. However inconsistencies in study design, treatments and 
included population that raise questions of the validity of some study 
results. Additionally, only a couple of IMs where examined in every 
study, so no complete image of the inflammatory response of the sub-
jects was formed [13]. 
Studies assessing the association between the presence of selected 
bacterial species/groups in the apical root canal and expression of me-
diators in apical periodontitis lesions have been conducted [15,16]. In 
these studies the different immunologic reactions locally have been 
associated with differences in root-canal microbiome. To our knowl-
edge, no determination has been made of whether IMs are as a result 
differentially expressed in peripheral blood. 
Therefore, the first purpose of this study is to confirm the current 
evidence that concentrations of 18 different peripheral systemic IMs in 
AP subjects differ from controls. The second purpose of this study is to 
investigate in AP-subjects the course of the inflammatory response, 
measured in peripheral blood plasma before and after AP treatment with 
tooth extraction. The third purpose is to map the root canal infection and 
to correlate its composition with the inflammatory response. 
2. Objectives 
Primary objectives: (i) To compare the plasma concentrations of 
inflammatory mediators of AP subjects to non-AP controls, (ii) to eval-
uate whether elimination of the endodontic infection reduces systemic 
inflammation and finally (iii) to investigate the microbiome of root 
canal infections. 
Secondary objectives: i) to correlate the inflammatory mediator 
data with the microbiome data to find out whether the type of infection 
influences the type and severity of the inflammatory response and res-
olution thereof, ii) to examine clusters and patterns in the inflammatory 
mediator data before and after tooth extraction in order to establish a 
biomarker signature of AP. 
3. Study design 
This is a multi-centre prospective case-control intervention study in 
which subjects will be followed for 19 weeks. 
Thirty subjects with 1 or 2 teeth with apical periodontitis to be 
treated with tooth extraction will be included. Six peripheral blood 
samples (S1 – S6; Fig. 1) will be drawn from an antecubital vein in a 
period from 6 weeks before to 13 weeks after tooth extraction. Sample 
S3 will be acquired before local anaesthesia is administered, thus before 
tooth extraction. 
Following tooth extraction, the tooth will be collected for microbial 
analysis. The plasma concentrations of 21 inflammatory mediators will 
be measured. 
Thirty healthy subjects without AP who will be matched for age and 
sex will serve as controls. From the control subjects blood will be drawn 
6 times in 19 weeks. To limit the effect of seasonal fluctuation, blood 
draw of the matching cases and controls will take place within 14 days. 
3.1. Study population 
3.1.1. Recruitment 
The subjects will be recruited from a referral dental practice limited 
to endodontics, from a referral dental practice limited to implantology 
as well as from 6 general dental practices. 
The control group subjects will also be recruited, from the same 
practices, that respond to flyers and posters displayed in the waiting 
rooms with an invitation for healthy volunteers with no dental problems 
to participate in the study. A database will be created with the informa-
tion of individuals, that wish to participate. Once a AP case is included a 
matched individual (for sex and age) will identified from the control 
database and the individual contacted for inclusion into the study. 
3.1.2. Inclusion criteria for AP subjects 
In order to be eligible to participate in this study, a subject will have 
to meet all of the following criteria.  
- The subject is 18–80 years old.  
- After intra-oral examination, AP should be confirmed with an intra- 
oral radiograph appearing on the radiograph as a radiolucent area 
around one or more root tips of the affected tooth. AP will be diag-
nosed when in the periapical region, the periodontal ligament space 
is at least twice as wide as in the mid-root regions. A root canal 
treatment should have a poor prognosis or the patient would rather 
have the affected tooth extracted.  
- No other teeth have AP. To confirm this, teeth will be clinically 
examined. Discolored teeth or teeth with restorations that will not 
respond to cold testing or that were tender to percussion or palpation 
will also be examined with an intra-oral radiograph. In the (pre) 
molar region, recent bite-wing radiographs will be used to screen for 
deep restorations or dental caries. When there will be doubts about 
the vitality of restored or decayed (pre)molars an additional radio-
graph will be taken. AP will be diagnosed when in the periapical 
region, the periodontal ligament space is at least twice as wide as in 
the mid-root regions.  
- The subject will complete the medical history questionnaire.  
- The subjects volunteer to participate and donate 6 blood samples at 6 
different time points and the subject will also have to donate the 
extracted tooth. 
List of abbreviations 
AP Apical periodontitis, root-tip inflammation 
CBCT Cone-beam computer tomography 
DMFT Decayed missing and filled teeth 
DPSI Dutch periodontal scoring index 
IL-x Interleukin, a pro- or anti-inflammatory molecule in 
blood plasma 
IMs Inflammatory mediators, molecules that initiate, 
sustain or resolve an inflammatory response 
MREC Medical research ethics committee 
MSD Mesoscale discovery platform for inflammatory 
mediator detection 
OTU Operational taxonomic unit 
WMO Wet medisch-wetenschappelijk onderzoek met mensen  
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- The subject will not undergo dental hygienist’ treatment during the 
study.  
- The periodontium of the subject is healthy (Dutch Periodontal 
Scoring Index Category A, DPSI index of maximum 2) [17]. 
3.1.3. Inclusion criteria for control subjects 
In order to be included in the study a control subject will have to 
meet the following criteria:  
- The subject is 18–80 years old.  
- No teeth have AP. To confirm this, teeth will be clinically examined. 
Discolored teeth or teeth with restorations that will not respond to cold 
testing or that were tender to percussion or palpation will also be 
examined with an intra-oral radiograph. In the (pre)molar region, 
recent bite-wing radiographs will be used to screen for deep restora-
tions or dental caries. When there will be doubts about the vitality of 
restored or decayed (pre)molars an additional radiograph will be taken.  
- The subject will complete the medical history questionnaire.  
- The subjects volunteer to participate and donate 6 blood samples at 6 
different time points. 
3.1.4. Exclusion criteria 
A potential subject who meets any of the following criteria will be 
excluded from participation in this study:  
- smoking  
- pregnancy or lactation  
- diabetes mellitus  
- chronic inflammatory diseases such as Crohn’s disease, hepatitis etc.  
- use of antibiotics 1 month prior  
- use of corticosteroids or NSAIDs  
- chemotherapy or previous head/neck irradiation  
- any surgery 6 months prior  
- extra-oral swelling pre-operatively  
- malaise, colds or influenza  
- dental prosthesis carriers with stomatitis  
- absence of periapical radiolucency in the presence of tenderness to 
percussion. 
- absence of periapical radiolucency in the absence of a positive sen-
sibility test of the dental pulp  
- previous surgery on tooth considered 
3.1.5. Late exclusion 
Late exclusion can occur when during the following visits:  
- the healing is compromised, like alveolitis  
- other infection related inflammations occur  
- the use of antibiotics for any infection  
- the use of corticoids to manage any inflammation.  
- dental hygienist visit during the course of the study  
- change in health/surgery of any kind  
- taking up smoking  
- other changes in lifestyle 
3.1.6. Sample size calculations 
To answer the main question which is to compare cases versus 
controls a sample size has been calculated with G*Power software. 
(G*Power 3.1.9.2 software Franz Faul, Universitaet Kiel, Germany) with 
data retrieved from previous scientific papers where the levels of chosen 
mediators were determined in serum: for CRP [18]with values 6.6 ± 4.2 
mg/L for subjects with AP and 3.9 ± 1.8 mg/L for subjects without AP., 
for IL-1β [19] with values 225.12 ± 43.72 pg/ml for case and 77.52 ±
31.05 pg/ml for controls and for IL-17A [20] with values 12.48 ± 2.00 
pg/ml for cases and 4.43 ± 0.54 pg/ml for controls. 
The data will be analyzed statistically utilizing a parametric two- 
tailed independent t-test in comparison of health and disease. The 
power is set at 80% with an alpha <0.05. Calculated sample sizes were n 
= 17 (CRP), n = 17 (IL-1β) and n = 15 (IL-17a). These group sizes will 
also exceed 80% statistical power in the dependent statistical tests, 
namely the longitudinal data analysis. 
In the likely case the data are not normally distributed a non- 
parametric test (Mann-Whitney U) will be used. Then the sample sizes 
are calculated at n = 22 (CRP), n = 22 (IL-1β) and n = 20 (IL-17A). 
Considering possible no-shows or late exclusion, the group sizes are 
set at n = 30 for the intervention group and n = 30 for the controls 
without AP. The aim was to acquire complete datasets for at least 25 AP 
plus 25 control subjects. 
4. Study procedures  
4.1. Blood plasma 
Blood will be collected by venipuncture of an antecubital vein using 
Fig. 1. Workflow of the study protocol after the study inclusion.  




Proceedings in every visit.  
visit 
number 
weeks to (− ) or from (+) tooth 
extraction 
procedures 
S1 − 6  - following completion of a medical history form and signing of the informed consent form an intra-oral examination in which the number of decayed, missing and filled teeth (DMFT) will be 
recorded. Periodontal health will be registered with the Dutch Periodontal Screening Index (DPSI). 
- if recent radiographs are not available, the oral examination will be completed with a radiographic examination with bite-wing radiographs and if necessary additional intra-oral ra-
diographs (in case of deep caries, deep restorations, restoration material in the pulp chamber, tooth discoloration, tenderness to percussion and no response to cold testing).  
- give one 10 mL tube of peripheral blood by antecubital venepuncture 
S2 − 3  - give an oral update on their medical history  
- give one 10 mL tube of peripheral blood by antecubital venepuncture 
S3 0  - give an oral update on their medical history  
- give one 10 mL tube of peripheral blood by antecubital venepuncture  
- will have treatment consisting of  
1) local anaesthesia  
2) Tooth extraction per forceps (if required use of elevator and surgical burr/alveolotomy). Removal of inflammatory tissue from the socket by curretage.  
3) Suturing with non-absorbable braided polyester (Ethibond-Excel 4–0, Ethicon, Cincinatti OH, USA), 1–3 sutures.  
4) Placement of an aseptic gauze on the wound (patient has to apply pressure for 30 min).  
- collection and storage of extracted tooth 
S4 +1  - will give an update on their medical history  
- will undergo an intra-oral inspection of the extraction wound  
- will have the sutures removed  
- give one 10 mL tube of peripheral blood by antecubital venepuncture 
S5 +6  - give an update on their medical history  
- give one 10 mL tube of peripheral blood by antecubital venepuncture 
S6 +13  - give an update on their medical history  
- give one 10 mL tube of peripheral blood by antecubital venepuncture   
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the Vacutainer system (Greiner Bio-One, Alphen aan den Rijn, 
Netherlands), 9–10 mL in an EDTA plasma tube. Immediately thereafter, 
the tube with the blood will be centrifuged 10 min × 1000 G and the 
supernatant plasma (~4 mL) will be taken. Then, the plasma will be 
cooled to 4 ◦C and transported to ACTA. There, the plasma will be ali-
quoted in 0.5-mL aliquots in 1.5-mL microcap centrifuge tubes and 
stored frozen at − 80 ◦C. Transportation and storage will occur within 24 
h of the blood draw. 
4.2. Inflammatory mediators 
Eighteen markers have been selected from our opinion [21] and a 
Mesoscale Discovery assay (Mesoscale Diagnostics, Rockville MA, USA) 
will be employed to profile the EDTA-plasma samples. 
The selected markers are CRP, IL-8/CXCL-8, MIP-1, MIP-2/CXCL-2, 
GCSF, IL-1α, IL-1β, TNF- α, IL-4, IL-6, IL-10, IL-12, IL-17A, interferon 
γ, IFN-γ inducing factor (IGIF), VEGF, RANKL, OPG. 
4.3. Dental microbiota 
Processing the extracted teeth will be according to a previously 
published protocol [22]. After extraction, the teeth will be stored at − 80 
◦C until cryo-pulverisation. For microbial DNA isolation, the outer sur-
face of the tooth will be wiped off repeatedly with a piece of gauze 
soaked in 0.5% sodium hypochlorite (NaOCl). The tooth then will be 
placed in a sodium thiosulfate solution to inactivate the NaOCl. The 
samples will be cryo-pulverized with the use of a freezer mill (Spex 
Certiprep, Metuchen, NJ, USA) and the powdered teeth stored frozen at 
− 80 ◦C. 
Samples will be transferred to a sterile screwcap Eppendorf tube with 
0.25 mL of lysis buffer (AGOWA mag Mini DNA Isolation Kit; Agowa, 
Berlin, Germany). Then, 0.3 g of zirconium beads (diameter, 0.1 mm; 
Biospec Products, Bartlesville, OK, USA) and 0.2 mL of phenol will be 
added to each sample and the samples homogenised with a Mini-bead 
beater (Biospec Products) for 2 min. DNA will be extracted with the 
AGOWA mag Mini DNA Isolation Kit and quantified (Nanodrop ND- 
1000; NanoDrop Technologies, Montchanin, DE, USA). 
For deep microbiome profiling the bacterial composition of each 
sample will be determined using bar-coded illumina MiSeq sequencing 
of the hypervariable V4 region of bacterial 16S rDNA. Sequencing data 
processing will be undertaken using QIIME, sequences will be clustered 
in operational taxonomic units (OTUs) and assigned to taxonomy. For 
metagenomic sequencing the extracted genomic DNA will be physically 
sheared to an average fragment size of 250 bp. The fragmented genomic 
DNA will be sequenced bi-directionally on a lane of an Illumina High-
Seq. From the sequencing data human sequences will be filtered out 
using BMTagger and functional profiles will be determined using 
existing software packages (e.g. HUMAnN). 
4.4. Withdrawal of individual subjects 
Subjects can withdraw from the study at any time for any reason if 
they wish to do so without any consequences. The investigator will 
withdraw a subject from the study when any of the late exclusion criteria 
are met. 
The recruitment period will continue until the calculated sample size 
has been reached. If a case-subject drops out, participation of the 
matched control will be discontinued also. Prior to the start of the study, 
the control subjects will be informed about this condition. 
4.5. Follow-up of subjects withdrawn from treatment 
Withdrawn subjects will be contacted to determine whether there 
has been an adverse event or serious adverse event. Subjects who fail to 
show up for the follow-up session will also be contacted to inquire 
whether they had forgotten the appointment and to schedule a new 
appointment. 
4.6. Study parameters 
4.6.1. Primary study parameters 
Blood-plasma concentrations of mediators of inflammation. 
Composition and function profile of the root canal infection. 
4.6.2. Other study parameters 
Subject characteristics: signs or symptoms of AP, number of decayed, 
missing and filled teeth and Dutch periodontal scoring indices, age and 
sex are used to describe the study population. 
4.7. Statistical analyses 
The data will be entered into SPSS (IBM SPSS Statistics for Windows, 
Version 25.0. Armonk, NY: IBM Corp) and in STATA. The level of con-
fidence is determined at 95%, α = 0.05. 
4.7.1. General 
In order to assess the normality of the data, we will visually inspect 
the Normal Q-Q Plots of the data. To test for normality, we will also use 
the Shapiro-Wilk test (with p > 0.05 the data will be considered normal) 
and test for equal homogeneity of variances (Levene’s test of variance). 
In case the data are normally distributed parametric tests will be 
employed. 
When the data are not normally distributed, non-parametric statis-
tical tests will be employed after transformation of the data. The sample 
size has been determined to be large enough for non-parametric 
analyses. 
4.7.2. Primary objectives  
(i) Comparison AP and controls 
Parameter means will be compared between AP patients and controls 
using independent samples Students t-tests.  
(ii) Within subject measurements before and after 
Linear mixed models with correction for baseline will be performed 
in order to analyse the longitudinal data. First a crude analysis will be 
performed, which will be followed by an adjusted analysis for sex and 
age.  
(iii) OTUs are registered and the prevalence of the OTUs will be 
calculated. 
4.7.3. Secondary objectives 
Pearson’s r is used to correlate between the prevalent OTUs and the 
concentrations of inflammatory mediators in blood plasma. 
Clusters of inflammatory mediators are determined and analysed 
with K-means analyses with a maximum iteration of 10. The blood 
plasma samples will be grouped by their presence and concentrations 
but can also be referenced to the clinical variables. One-way ANOVA will 
be used to test for differences in expression Z-scores between the 
clusters. 
4.7.4. Missing data 
Missing data will not be imputed. Data from drop-out subjects will be 
used wherever possible. Data from subjects who have withdrawn their 
consent will be requested if it has already been collected and that data 
can be used for analysis. 
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4.8. Ethical considerations 
4.8.1. Regulation statement 
This study will be conducted according to the principles of the 
Declaration of Helsinki (10th version, October 2013) (www.wma.net) 
and in accordance with the Medical Research Involving Human Subjects 
Act (WMO). 
4.8.2. Consent 
Every subject eligible for participation in the study will be informed 
about the study by their dentist or the coordinating investigator. If he/ 
she is interested they receive a patient information sheet and the leaflet 
‘Medisch-wetenschappelijk onderzoek: Algemene informatie voor de 
proefpersoon’. Eligible subjects will be instructed to contact the coor-
dinating investigator when they are interested in participation in the 
study. Subjects give their consent by signing a consent form, but can 
withdraw from the study at any time and without having to give a reason 
for withdrawal. Withdrawal the study will not affect the current or 
future treatments. 
4.8.3. Approvals 
The study has been approved by the Board of Directors of ACTA. 
The study protocol has been approved by the MREC of VU Medical 
Centre in Amsterdam number 2016/187, NL54832.029.16. 
5. Discussion 
Some IMs that initiate or sustain the inflammatory response are not 
produced at the site of insult but elsewhere in the body. While being 
transported via the blood stream to the site of inflammation, it is 
believed that these IMs may also trigger a response in other cells that are 
encountered on their journey. On the other hand, IMs that are produced 
at the site of inflammation may spill into the circulation and thus add to 
systemic inflammation [1]. At present, associations between oral 
inflammation and systemic disease have been identified with recent 
articles finding associations between apical periodontitis (AP) and car-
diovascular disease and specifically subclinical atherosclerosis [11,23]. 
No causal relationships have been established. However, little is known 
about the impact of AP on healthy individuals. 
Some studies have investigated the peripheral blood of subjects and 
very recently, AP has indeed been associated with elevated concentra-
tions of pro-inflammatory mediators in peripheral blood compared to 
controls [13]. These IMs are C-reactive protein (CRP), interleukin-6 
(IL-6) and asymmetric dimethylarginin (ADMA) which are all 
pro-inflammatory molecules. In the subjects that were involved in these 
studies, CRP concentrations were so high that they potentially increase 
the risk of cardiovascular disease [24,25]. 
If there is a causal connection: namely that AP causes the increase in 
systemic IMs, then it is expected to find a decrease in pro-inflammatory 
mediators after treatment of AP. However, the currently available 
literature has not revealed such a decline in IMs after treatment of AP 
(except for complement factor C3 in two studies [26,27]). Great varia-
tion in study designs may explain the lack of a unanimous answer to the 
question of whether AP treatment reduces the systemic inflammatory 
burden. For instance, in the current literature the treatments of AP vary 
from tooth extraction, root canal treatment to antibiotics and abscess 
incisions. Furthermore, great variation in follow-up time points has been 
reported [13]. This variation in all the studies creates the luck of clarity 
of whether the treatment had actually removed the infection and 
consequently the inflammation on histological level is resolved since the 
effectiveness is questionable. Realistically, the only treatment that leads 
to a certain resolution of inflammation is the extraction of the involved 
tooth where the infection is eliminated with removal of the tooth. 
Additionally, until now the only way to assess the success of a root- 
canal treatment and the resolution of inflammation is by radiographic 
assessment. Due to the need for boney healing to occur to visualize 
healing, several months have to elapse, sometimes even longer. Radio-
graphic assessment can be achieved either by 2-dimensional (periapical 
radiograph) or 3-dimensional (Cone Beam CT (CBCT)) means. There are 
significant statistical differences in studies assessing periapical radio-
graphs and CBCTs, that have implications for periapical diagnosis and 
for evaluating the outcome of endodontic care [28]. The diagnostic 
validity, even of 3-dimensional radiographic imaging, especially after 
endodontic surgery is quite low, with studies showing that up to 42% did 
not represent actual active inflammatory lesions [29]. Thus there is a 
need for an alternative diagnostic tool that can determine if inflamma-
tion has resolved. It is expected that this study will help towards 
achieving this goal. Having good certainty that the inflammation is 
resolved, as the tooth will be extracted, and by examining patterns of 
IMs in the blood, we can establish blood tests as diagnostic markers for 
treatment success. In that case the doubt of the radiograph will be 
eliminated and we would have a simple radiation-free diagnostic tool. 
Additionally there is no study, to our knowledge, that has assessed 
whether there is a connection between the microbiome of the root-canal 
and the IMs in peripheral blood. With current next-generation 
sequencing techniques it has become clear that endodontic infections 
are polymicrobial and that the composition greatly varies even within 
one root [22,30]. There is yet much to understand of the function of 
these microbiota in root canal infections and it would be interesting and 
indeed possibly important to determine which species are involved in 
the endodontic microbiome and if they can be correlated to certain IMs. 
Inflammatory responses are dynamic and responsive to challenges 
and thus, for establishing an impact of AP on systemic inflammation an 
intervention type study is to be conducted [21]. Proof that endodontic 
intervention reduces systemic inflammation in subjects with AP can be 
provided with a prospective cohort study where subjects are followed in 
time before and after an intervention. Non-AP subjects should be 
included as controls. For the resolution of AP, elimination of the infec-
tion is mandatory and this can be achieved in two ways: with root-canal 
treatment or with tooth extraction. Root-canal treatment is not always 
effective because bacteria can remain due to the complexity of the root 
canal system [31,32]. Extraction of the infected tooth, however, results 
in quick and complete resolution of AP [33,34]. Tooth extraction how-
ever will elicit an inflammatory response which is triggered by the tissue 
damage of the procedure. Therefore, the follow-up of individuals should 
be long enough to be able to measure IMs in the healed situation. 
Resolution of inflammation is an active process and not simply a 
‘turning off’ of pro-inflammatory pathways. A whole cascade of anti- 
inflammatory mediators is initiated to clear the site from inflamma-
tory cells. In the case of AP, due to the need for repair of the bone defect 
in the jaw, we assume that also bone-stimulatory molecules should be 
produced. In the proposed study, besides evaluating the pro- 
inflammatory mediators, we also wish to include analyses of anti- 
inflammatory and bone stimulatory mediators. This will give greater 
insight into the resolution of AP and possibly a pattern in IMs expression 
that correlates with AP and the healing of AP [21]. In order to address 
the research questions about the function of the microbiome and its 
correlation with systemic inflammation from the extracted teeth, the 
microbial DNA is obtained and composition will be determined. 
In conclusion, with the results of this study, a causal relationship 
between AP and systemic inflammation can hopefully be established. 
Moreover, this study will give insight into biomarkers of inflammation 
which can be used as a future diagnostic tool for the presence of AP and 
its resolution after root canal treatment. 
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